Screening for medullary thyroid carcinoma with serum calcitonin measurements in patients with thyroid nodules in the United States and Canada

Thyroid

Volumn 21, Issue 11, 2011, Pages 1199-1207

  Daniels, Gilbert H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; PENTAGASTRIN;

ADULT; AGING; ARTICLE; CALCITONIN BLOOD LEVEL; CANADA; CANCER SCREENING; CANCER SURGERY; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HORMONE ACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; THYROID MEDULLARY CARCINOMA; THYROID NODULE; UNITED STATES;

CALCITONIN; CANADA; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; PENTAGASTRIN; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; THYROID NODULE; UNITED STATES;

EID: 83755186103     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2010.0297     Document Type: Article

References (61)

1. Machens A, Dralle H 2010 Biomarker-based risk stratification for previously untreated medullary thyroid cancer. J Clin Endocrinol Metab 95:2655-2663.
2. Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, Devesa SS 2009 Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev 18: 784-791.
3. Kebebew E, Ituarte PH, Siperstein AE, Duh QY, Clark OH 2000 Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 88:1139-1148. (Pubitemid 30127676)
4. Hundahl SA, Fleming ID, Fremgen AM, Menck HR 1998 A national cancer data base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 83: 2638-2648. (Pubitemid 29019586)
5. Herrmann BL, Schmid KW, Goerges R, Kemen M, Mann K 2010 Calcitonin screening and pentagastrin testing: predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease. Eur J Endocrinol 162:1141-1145.
6. Rink T, Truong PN, Schroth HJ, Diener J, Zimny M, Grün-wald F 2009 Calculation and validation of a plasma calci-tonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease. Thyroid 19:327-332.
7. Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M, Filetti S 2007 Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 92:450-455.
8. Vierhapper H, Niederle B, Bieglmayer C, Kaserer K, Baumgartner-Parzer S 2005 Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. Thyroid 15:1267-1272. (Pubitemid 41821761)
9. Gibelin H, Essique D, Jones C, Levillain P, Maréchaud R, Kraimps JL 2005 Increased calcitonin level in thyroid nodules without medullary carcinoma. Br J Surg 92:574-578. (Pubitemid 40685653)
10. Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L, Miccoli P, Iacconi P, Basolo F, Pinchera A, Pacini F 2004 Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 89:163-168. (Pubitemid 38183876)
11. Karanikas G, Moameni A, Poetzi C, Zettinig G, Kaserer K, Bieglmayer C, Niederle B, Dudczak R, Pirich C 2004 Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects. J Clin Endocrinol Metab 89:515-519. (Pubitemid 38269851)
12. Iacobone M, Niccoli-Sire P, Sebag F, De Micco C, Henry JF 2002 Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels. World J Surg. 26:886-890. (Pubitemid 36920281)
13. Hahm JR, Lee MS, Min YK, Lee MK, Kim KW, Nam SJ, Yang JH, Chung JH 2001 Routine measurement of serum calcito-nin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases. Thyroid 11:73-80. (Pubitemid 32140448)
14. Ozgen AG, Hamulu F, Bayraktar F, Yilmaz C, Tüzün M, Yetkin E, Tunçyürek M, Kabalak T 1999 Evaluation of routine basal serum calcitonin measurement for early diagnosis of medullary thyroid carcinoma in seven hundred seventy-three patients with nodular goiter. Thyroid 9:579-582. (Pubitemid 29296120)
15. Henry JF, Denizot A, Puccini M, Gramatica L, Kvachenyuk A, Conte Devolx B, De Micco C 1998 Latent subclinical medullary thyroid carcinoma: diagnosis and treatment. World J Surg 22:752-756.
16. Kaserer K, Scheuba C, Neuhold N, Weinhäusel A, Vier-happer H, Haas OA, Niederle B 1998 C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin. Am J Surg Pathol 22:722-728. (Pubitemid 28280274)
17. Vierhapper H, Raber W, Bieglmayer C, Kaserer K, Wein-häusl A, Niederle B 1997 Routine measurement of plasma calcitonin in nodular thyroid diseases. J Clin Endocrinol Metab 82:1589-1593. (Pubitemid 27200439)
18. Niccoli P, Wion-Barbot N, Caron P, Henry JF, de Micco C, Saint Andre JP, Bigorgne JC, Modigliani E, Conte-Devolx B 1997 Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French medullary study group. J Clin Endocrinol Metab 82:338-341. (Pubitemid 27068587)
19. Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, Di Coscio G, Miccoli P, Pinchera A 1994 Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 78:826-829. (Pubitemid 24118072)
20. Elisei R 2008 Routine serum calcitonin measurement in the evaluation of thyroid nodules. Best Pract Res Clin En-docrinol Metab 22:941-953.
21. Rossi G, Corsello SM, Corrado S, Fadda G, Di Donato C, Pontecorvi A 2010 Nodular disease and parafollicular C-cell distribution: results from a prospective and retrospective clinico-pathological study on the thyroid isthmus. Eur J Endocrinol 162:137-143.
22. Bjerre Knudsen L, Madsen LW, Andersen S, Almholt K, de Boer AS, Drucker DJ, Gotfredsen C, Egerod FL, Hegelund AC, Jacobsen H, Jacobsen SD, Moses AC, Mølck AM, Nielsen HS, Nowak J, Solberg H, Thi TD, Zdravkovic M 2010 Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation. Endocrinology 151:1473-1486.
23. d'Herbomez M, Caron P, Bauters C, Cao CD, Schlienger JL, Sapin R, Baldet L, Carnaille B, Wémeau JL; French Group GTE (Groupe des Tumeurs Endocrines) 2007 Reference range of serum calcitonin levels in humans: influence of calcitonin assays, sex, age, and cigarette smoking. Eur J Endocrinol 157:749-755.
24. Erdogan MF, Gursoy A, Kulaksizoglu M 2006 Long-term effects of elevated gastrin levels on calcitonin secretion. J Endocrinol Invest 29:771-775. (Pubitemid 44869420)
25. Giovanella L, Suriano S 2011 Spurious hypercalcitoninemia in patients with nodular thyroid disease induced by heterophilic antibodies. Head Neck 33:95-97.
26. Bugalho MJ, Santos JR, Sobrinho L 2005 Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement. J Surg Oncol 91:56-60. (Pubitemid 40967381)
27. Scheuba C, Kaserer K, Bieglmayer C, Asari R, Riss P, Drosten R, Niederle B 2007 Medullary thyroid micro-carcinoma recommendations for treatment-a single-center experience. Surgery 142:1003-1010. (Pubitemid 350184107)
28. Karga H, Giagourta I, Papaioannou G, Doumouchtsis K, Polymeris A, Thanou S, Papamichael K, Zerva C 2011 Changes in risk factors and Tumor Node Metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum calcitonin. Metabolism 60:604-608.
29. Mazzaferri EL 1993 Management of a solitary thyroid nodule. N Engl J Med 328:553-559. (Pubitemid 23053833)
30. Hegedüs LN 2004 Clinical practice: the thyroid nodule. N Engl J Med 351:1764-1771.
31. Gharib H, Papini E 2007 Thyroid nodules: clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am 36:707-735. (Pubitemid 47135591)
32. Guth S, Theune U, Aberle J, Galach A, Bamberger CM 2009 Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination. Eur J Clin Invest 39:699-706.
33. Bernet V 2010 Approach to the patient with incidental papillary microcarcinoma. J Clin Endocrinol Metab 95:3586-3592.
34. Lang W, Borrusch H, Bauer L 1988 Occult carcinomas of the thyroid: evaluation of 1,020 sequential autopsies. Am J Clin Pathol 90:72-76.
35. Furmanchuk AW, Roussak N, Ruchti C 1993 Occult thyroid carcinomas in the region of Minsk, Belarus: an autopsy study of 215 patients. Histopathology 23:319-325. (Pubitemid 23316279)
36. Komorowski RA, Hanson GA 1988 Occult thyroid pathology in the young adult: an autopsy study of 138 patients without clinical thyroid disease. Hum Pathol 19:689-696.
37. Bondeson L, Ljungberg O 1981 Occult thyroid carcinoma at autopsy in Malmö, Sweden. Cancer 47:319-323. (Pubitemid 11179328)
38. Autelitano F, Spagnoli LG, Santeusanio G, Villaschi S, Au-telitano M 1990 Occult carcinoma of the thyroid gland: an epidemiological study of autopsy material. Ann Ital Chir 61:141-146. (In Italian.) (Pubitemid 20312629)
39. E Kovács GL, Gonda G, Vadász G, Ludmány E, Uhrin K, Görömbey Z, Kovács L, Hubina E, Bodó M, Góth MI, Sza-bolcs I 2005 Epidemiology of thyroid microcarcinoma found in autopsy series conducted in areas of different iodine intake. Thyroid 15:152-157.
40. Thorvaldsson SE, Tulinius H, Björnsson J, Bjarnason O 1992 Latent thyroid carcinoma in Iceland at autopsy. Pathol Res Pract 188:747-750.
41. Nielsen B, Zetterlund B 1985 Malignant thyroid tumors at autopsy in a Swedish goitrous population. Cancer 55: 1041-1043. (Pubitemid 15128665)
42. Machens A, Hoffmann F, Sekulla C, Dralle H 2009 Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer. Endocr Relat Cancer 16:1291-1298.
43. Doyle P, Düren C, Nerlich K, Verburg FA, Grelle I, Jahn H, Fassnacht M, Mäder U, Reiners C, Luster M 2009 Potency and tolerance of calcitonin stimulation with high-dose calcium versus pentagastrin in normal adults. J Clin Endocrinol Metab 94:2970-2974.
44. Hasselgren M, Hegedüs L, Godballe C, Bonnema SJ 2010 Benefit of measuring basal serum calcitonin to detect medullary thyroid carcinoma in a Danish population with a high prevalence of thyroid nodules. Head Neck 32:612-618.
45. Cherenko M, Slotema E, Sebag F, De Micco C, Henry JF 2010 Mild hypercalcitoninaemia and sporadic thyroid disease. Br J Surg 97:684-690.
46. Carney JA, Sizemore GW, Hayles AB 1978 Multiple endocrine neoplasia, type 2b. Pathobiol Annu 8:105-153.
47. Etit D, Faquin WC, Gaz R, Randolph G, DeLellis RA, Pilch BZ 2008 Histopathologic and clinical features of medullary microcarcinoma and C-cell hyperplasia in prophylactic thyroidectomies for medullary carcinoma: a study of 42 cases. Arch Pathol Lab Med 132:1767-1773.
48. Guyétant S, Rousselet MC, Durigon M, Chappard D, Franc B, Guerin O, Saint-André JP 1997 Sex-related C cell hyper-plasia in the normal human thyroid: a quantitative autopsy study. J Clin Endocrinol Metab 82:42-47. (Pubitemid 27021268)
49. Santeusanio G, Iafrate E, Partenzi A, Mauriello A, Autelitano F, Spagnoli LG 1997 A critical reassessment of the concept of C-Cell hyperplasia of the thyroid: a quantitative immuno-histochemical study. Appl Immunohistochem 5:160-172.
50. Scheuba C, Kaserer K, Kotzmann H, Bieglmayer C, Niederle B, Vierhapper H 2000 Prevalence of C-cell hyperplasia in patients with normal basal and pentagastrin-stimulated calcitonin. Thyroid 10:413-416. (Pubitemid 30418746)
51. Hodak SP, Burman KD 2004 Editorial: the calcitonin conundrum-is it time for routine measurement of serum calcitonin in patients with thyroid nodules? J Clin Endocrinol Metab 89:511-514. (Pubitemid 38269850)
52. Karges W, Dralle H, Raue F, Mann K, Reiners C, Grussen-dorf M, Hü fner M, Niederle B, Brabant G; German Society for Endocrinology (DGE)-Thyroid Section 2004 Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes 112:52-58. (Pubitemid 38220433)
53. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JWA, Wiersinga W, European Thyroid Cancer Taskforce 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803. (Pubitemid 43997716)
54. Costante G, Durante C, Francis Z, Schlumberger M, Filetti S 2009 Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls. Nat Clin Pract En-docrinol Metab 5:35-44.
55. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM; American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules
56. and Differentiated Thyroid Cancer 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214.
57. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, He-gedüs L, Vitti P; AACE/AME/ETA Task Force on Thyroid Nodules 2010 American Association of Clinical En-docrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 16 Suppl 1:1-43.
58. Cheung K, Roman SA, Wang TS, Walker HD, Sosa JA 2008 Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis. J Clin Endocrinol Metab 93:2173-2180. (Pubitemid 351831532)
59. Borget I, De Pouvourville G, Schlumberger M 2007 Editorial: Calcitonin determination in patients with nodular thyroid disease. J Clin Endocrinol Metab 92:425-427.
60. Bhanot P, Yang J, Schnadig VJ, Logroño R 2007 Role of FNA cytology and immunochemistry in the diagnosis and management of medullary thyroid carcinoma: report of six cases and review of the literature. Diagn Cytopathol 5:285-292. (Pubitemid 46652562)
61. Walter MA, Meier C, RadimerskiT, Iten F,KränzlinM,Müller-Brand J, de Groot JW, Kema IP, Links TP, Müller B 2010 Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer. Cancer 116:31-40.